Please login to the form below

Not currently logged in
Email:
Password:

Incanthera appoints Laura Brogden as CFO

She joins from Summ.it

Drug development and targeted cancer medicines group Incanthera has appointed Laura Brogden as its new chief financial officer.

She said: “Having known the company for many years, I am thrilled to take the position at such a pivotal and exciting time, and I am very much looking forward to the plans ahead in the immediate future.”

With over 17 years’ industry experience, Brogen joins the University of Bradford spin-out from Summ.it, where she was responsible for a portfolio of entrepreneurial clients covering venture capital and private equity businesses.

Simon Ward, chief executive officer, Incanthera, said: “Laura is a fantastic addition to the Incanthera team, as someone well known to us through heading the finances for Incanthera at Summ.it, we are delighted that she has accepted the position within the company and the board.”

24th October 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics